Search

everythinglearnresearchcommunity

for

Search:↓

Overweight women with PCOS are more likely to have excess male hormones.

New understanding and treatments for hair loss are improving, but more research is needed.

Using existing drugs for new purposes could be a cost-effective way to treat chest pain and non-clogged heart arteries, with some drugs for lung blood pressure showing promise but needing more testing.

Biologic therapies can cause various adverse events, but allergy/immunology clinicians can manage them.

Vitamin D deficiency is linked to a higher chance of metabolic syndrome in women with PCOS.

The main prostate diseases in dogs are benign growth, infections, and cancer, with various treatments ranging from drugs to surgery, but cancer treatments have limited success.

The document concludes that more research is needed to reduce frequent hospital visits, addiction medicine education improves with specific training, early breast cancer surgery findings are emerging, nipple smears are not very accurate, surgery for older melanoma patients doesn't extend life, a genetic condition in infants can often be treated with one drug, doctors are inconsistent with blood clot medication, a certain gene may protect against cell damage, muscle gene overexpression affects many other genes, and some mitochondrial genes are less active in mice with tumors.

Certain gene variations may protect against skin issues and oxidative stress in women with PCOS.

Women with PCOS who have low SHBG are more likely to have low good cholesterol and metabolic syndrome.

ADT, especially enzalutamide, may increase the risk of heart rhythm problems and sudden death in men.

Model improves accuracy in predicting hair loss effects.

While PCOS might increase the risk of heart disease, there's not strong evidence to prove it causes earlier heart problems.

Lifestyle changes can improve body composition, excess male hormone levels, and insulin resistance in women with PCOS.

Erectile dysfunction is increasingly common in men under 40, with many physical and psychological causes, and various treatment options available.

High androgen levels in young women with PCOS are linked to higher blood pressure.

Hair loss linked to higher heart disease risk in both men and women.

Some birth control pills have a higher risk of blood clots than others.

Liraglutide caused significant weight loss in some obese women with PCOS, especially those with severe obesity and insulin resistance.

The conclusion is that androgen receptor gene polymorphism might be a marker for polycystic ovary syndrome, but more research is needed.

G allele of AR Stul polymorphism linked to higher hair loss risk, especially in white people.

Finasteride may cause suicidal thoughts and mental side effects, especially in young people with hair loss.

Most patients with Porphyria Cutanea Tarda had skin blisters and were often affected by hepatitis C and alcohol abuse, with differences between familial and sporadic cases.

More PDCD4 is linked to obesity, insulin problems, and cell death in ovaries for those with polycystic ovary syndrome.

Many young Italian women have hyperandrogenic disorders like PCOS, which are linked to age, body weight, and insulin resistance.

Skin problems like itching, dry skin, and hair loss are more common in hepatitis C patients after interferon treatment, but lichen planus is not linked to the infection.

Brazilian women with PCOS and both menstrual irregularity and high male hormone levels have a higher chance of having metabolic syndrome.

Early hair loss may indicate prostate issues.

Women with PCOS who had antiandrogenic treatment before pregnancy had fewer complications than those without treatment.

Certain scalp patterns can indicate the severity and activity of hair loss in Turkish alopecia patients.

Patients with chronic graft-versus-host disease often have skin problems like vitiligo and alopecia areata.